THERAPY INTERRUPTED

Adverse reaction reported in 12,752 FDA reports across 13 drugs.

12,752
Total Reports
13
Drugs Involved
Relugolix
Most Reported Drug

Drugs Associated with THERAPY INTERRUPTED

Drugs where "THERAPY INTERRUPTED" was reported as an adverse event.

# Drug Reports % of Total
1 Relugolix 3,298
25.9%
2 Upadacitinib 1,800
14.1%
3 Amikacin 1,377
10.8%
4 Rifaximin 1,057
8.3%
5 Voclosporin 958
7.5%
6 Voxelotor 900
7.1%
7 Ixekizumab 826
6.5%
8 Bimekizumab 735
5.8%
9 Cenegermin-Bkbj 487
3.8%
10 Brivaracetam 480
3.8%
11 Abiraterone 459
3.6%
12 Icosapent Ethyl 197
1.5%
13 Baricitinib 178
1.4%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. The presence of a drug in this list does not mean the drug caused therapy interrupted. Always consult your healthcare provider.